Validation supports release. Real-world performance, workflow fit, and monitoring determine whether the product creates sustained value.
Medical Devices & Digital Health
AI for Medical Devices & Digital Health
Medical devices and digital-health products increasingly incorporate AI into systems that interact with patients, clinicians, data, and consequential workflows. GNS-AI works on the strategy, evidence, data, workflow integration, real-world performance, monitoring, governance, and Decision Control problems that emerge as these systems move into actual use.
Operating reality: AI performance remains an operating problem after development and validation.
Product, clinical, regulatory, quality, data science, digital health, postmarket, Responsible AI, governance, and executive leaders.
Beyond initial development.Evidence, workflow integration, real-world performance, and Decision Control after launch.
The operating problem
AI performance remains an operating problem after development and validation.
Once AI-enabled products interact with patients, clinicians, data, and consequential workflows, organizations still need evidence, monitoring, governance, and Decision Control for real-world use.
AI that is technically sound can still fail when handoffs, exceptions, and human roles are unresolved.
Where AI influences consequential actions, organizations need a basis for responsibility, oversight, and why AI was allowed to act.
Potential areas
Where GNS-AI works with medical-device and digital-health organizations.
Examples of relevant work. Not claims of completed client engagements in each area.
AI-enabled medical devices
Strategy, evidence, and operating support for AI that sits inside regulated device contexts.
Software as a medical device
Implementation, validation, and postmarket operating questions for SaMD products.
Clinical decision support
Workflow integration, evidence, and accountability where AI influences clinical decisions.
Remote monitoring
Data, alerting, review burden, and operating economics for monitoring programs.
Digital therapeutics
Real-world performance, adherence, evidence, and governance after launch.
Virtual care
AI-enabled virtual care workflows where handoffs and human authority remain material.
AI-enabled clinical workflows
Integration of AI into clinician and care-team workflows beyond the product boundary.
Real-world performance
Measure whether the AI system works under actual use conditions, not only development criteria.
Postmarket monitoring
Monitoring, signal detection, and operating governance after deployment.
Complaint analysis
Structured analysis of complaints and feedback tied to AI-influenced product behavior.
Signal analysis
Identify and interpret signals that may require investigation, control, or product change.
Operational governance
Accountability, oversight, and production practices around AI-enabled products.
Decision Control
Runtime Decision Control where AI materially influences consequential actions and responsibility must stay conditional on actual conditions.
How to buy
Start with the operating constraint.
Public entry points for medical-device and digital-health buyers. Other engagements are scoped.
Design
AI Initiative Review · $3,500
Five business days to pressure-test one product, evidence, or workflow initiative before more capital is committed.
See the Initiative ReviewProve
Pilot Efficacy & Scale Readiness
Evaluate whether a pilot or early deployment created enough real-world value and efficacy to justify broader use.
See Pilot EfficacyControl
Decision Control Assessment
3-4 weeks · Starts at $30,000 · Typical $30,000-$45,000. Evaluate one consequential workflow before persistent Decision Control.
See DCARuntime
Decision Control Plane
Persistent runtime Decision Control for consequential AI workflows. Scoped.
See DCPRelated markets
Devices and digital health sit alongside care delivery and payer work.
Hospital buyers should use Hospitals & Health Systems. Payer buyers should use Health Plans. Agency buyers should use Federal & Public Sector.
Ready to scope a medical devices or digital health engagement?
A 30-minute fit call confirms the next engagement, or no engagement.